0000927066-23-000117.txt : 20230512 0000927066-23-000117.hdr.sgml : 20230512 20230512212002 ACCESSION NUMBER: 0000927066-23-000117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230510 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rodriguez Javier CENTRAL INDEX KEY: 0001415548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 23917988 MAIL ADDRESS: STREET 1: 601 HAWAII ST. CITY: EL SEGUNDO STATE: CA ZIP: 90245 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wk-form4_1683940791.xml FORM 4 X0407 4 2023-05-10 0 0000927066 DAVITA INC. DVA 0001415548 Rodriguez Javier C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-05-10 4 M 0 88213 66.29 A 403835 D Common Stock 2023-05-10 4 D 0 58059 100.72 D 345776 D Common Stock 2023-05-10 4 F 0 13238 100.72 D 332538 D Common Stock 2023-05-10 4 S 0 15516 99.383 D 317022 D Common Stock 2023-05-10 4 S 0 1400 100.0443 D 315622 D Common Stock 2023-05-10 4 A 0 58780 0 A 374402 D Stock Appreciation Rights 66.29 2023-05-10 4 M 0 88213 0 D 2021-05-15 2023-05-15 Common Stock 88213 0 D Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the weighted average sale price of $99.383. The range of prices for the sale of these shares was $98.96 - $99.94 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average sale price of $100.0443. The range of prices for the sale of these shares was $99.99 - $100.12 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019, of which 100% will vest on May 15, 2023. The Stock Appreciation Rights were granted on May 15, 2018, which vested 50% each on May 15, 2021 and May 15, 2022. /s/ Stephanie N. Berberich, Attorney-in-Fact 2023-05-12